The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1030
July 3, 1998
View Complete Issue         Table of Contents 2019 
Hyaluronan Injections for Osteoarthritis of the Knee
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Hyaluronan Injections for Osteoarthritis of the Knee
July 3, 1998 (Issue: 1030)
Sodium hyaluronate (Hyalgan - Sanofi) and hylan G-F 20 (Synvisc - Wyeth- Ayerst) have been approved by the FDA for intra-articular injections in patients with knee pain due to osteoarthritis. Hylan G-F 20 is a cross-linked derivative of hyaluronic ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Hyaluronan Injections for Osteoarthritis of the Knee
Article code: 1030c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.